1.
Clin Infect Dis
; 67(9): 1441-1444, 2018 10 15.
Article
de Anglais
| MEDLINE
| ID: mdl-29878077
RÉSUMÉ
To assess MUC5AC as a biomarker for respiratory syncytial virus (RSV) disease severity, we tested nasal aspirates from RSV+ children with mild, moderate, and severe disease. Levels were significantly higher in those in the severe and moderate groups compared to mild group, indicating MUC5AC may be a useful biomarker for RSV disease severity.